Viridian Therapeutics
VRDN
#4803
Rank
NZ$2.66 B
Marketcap
$33.69
Share price
1.60%
Change (1 day)
-5.58%
Change (1 year)

Viridian Therapeutics (VRDN) - Cash on Hand

Cash on Hand as of September 2024 : NZ$1.33 Billion

According to Viridian Therapeutics's latest financial reports the company has NZ$1.33 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Viridian Therapeutics - Cash on Hand chart (from 2013 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2023-12-31NZ$0.75 B12.89%
2022-12-31NZ$0.66 B131.89%
2021-12-31NZ$0.28 B63.01%
2020-12-31NZ$0.17 B343.8%
2019-12-31NZ$39.86 M-57.21%
2018-12-31NZ$93.14 M39.44%
2017-12-31NZ$66.79 M1284.95%
2016-12-31NZ$4.82 M-69.52%
2015-12-31NZ$15.82 M142.24%
2014-12-31NZ$6.53 M2468.84%
2013-12-31NZ$0.25 M85.92%
2012-12-31NZ$0.13 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
NZ$0.48 B-63.84%๐Ÿ‡บ๐Ÿ‡ธ USA